Literature DB >> 8863668

Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens.

J Qian1, D G Bostwick, S Takahashi, T J Borell, J A Brown, M M Lieber, R B Jenkins.   

Abstract

Fluorescence in situ hybridization (FISH) is a powerful tool for quantitative analysis of chromosomes and genes and can be applied in a variety of specimens, including cell cultures, isolated nuclei from fresh and fixed tissues, and histological tissue sections. However, the results of FISH analysis of isolated nuclei in prostate cancer have not been previously compared with those from histological sections from the paraffin-embedded tissue blocks. To compare these methods, we studied isolated nuclei derived from 50-microns sections and adjacent 5-microns tissue sections from 10 cases of benign nodular hyperplasia of the prostate and 16 cases of prostatic carcinoma. FISH analysis employed centromere-specific probes for chromosomes 7, 8, 11, and 12. In benign tissue, the percentage of nuclei with three or more signals for chromosomes 7, 8, 11, and 12 was less than 3% for both isolated nuclei and tissue sections. However, the percentage of nuclei with no and one signals was less than 8% for isolated nuclei and more than 24% for tissue sections. In prostatic carcinoma, numeric chromosomal anomalies were found in 75% of cases by both FISH methods. However, isolated nuclei had more chromosomal tetrasomy than tissue sections (mean, 9.2 to 11.0% versus 5.1 to 5.6%, respectively). Conversely, intratumor heterogeneity of chromosomal anomalies was identified in 5 cases by FISH analysis of tissue sections but not in isolated nuclei. Cancer ploidy analysis by FISH correlated well with ploidy analysis by flow cytometry, although FISH was more sensitive for aneuploidy. We conclude that FISH analysis of isolated nuclei and histological tissue sections from paraffin blocks are reliable methods for detection of chromosomal anomalies in archival tissue of prostate cancer, although each method has advantages and disadvantages.

Entities:  

Mesh:

Year:  1996        PMID: 8863668      PMCID: PMC1865198     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  13 in total

1.  Thick-section fluorescence in situ hybridization on formalin-fixed, paraffin-embedded archival tissue provides a histogenetic profile.

Authors:  C T Thompson; P E LeBoit; P M Nederlof; J W Gray
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

2.  Trisomy 7: a potential cytogenetic marker of human prostate cancer progression.

Authors:  M G Bandyk; L Zhao; P Troncoso; L L Pisters; J L Palmer; A C von Eschenbach; L W Chung; J C Liang
Journal:  Genes Chromosomes Cancer       Date:  1994-01       Impact factor: 5.006

3.  Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing.

Authors:  O P Kallioniemi; T Visakorpi; K Holli; A Heikkinen; J Isola; T Koivula
Journal:  Cytometry       Date:  1991

4.  Model for the genetic evolution of human solid tumors.

Authors:  S E Shackney; C A Smith; B W Miller; D R Burholt; K Murtha; H R Giles; D M Ketterer; A A Pollice
Journal:  Cancer Res       Date:  1989-06-15       Impact factor: 12.701

5.  Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies.

Authors:  S Takahashi; J Qian; J A Brown; A Alcaraz; D G Bostwick; M M Lieber; R B Jenkins
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

6.  Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia.

Authors:  M R Emmert-Buck; C D Vocke; R O Pozzatti; P H Duray; S B Jennings; C D Florence; Z Zhuang; D G Bostwick; L A Liotta; W M Linehan
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

7.  Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pt3N0M0) prostate carcinoma.

Authors:  S Takahashi; A Alcaraz; J A Brown; T J Borell; J F Herath; E J Bergstralh; M M Lieber; R B Jenkins
Journal:  Clin Cancer Res       Date:  1996-01       Impact factor: 12.531

8.  Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias.

Authors:  J C Alers; P J Krijtenburg; K J Vissers; F T Bosman; T H van der Kwast; H van Dekken
Journal:  Genes Chromosomes Cancer       Date:  1995-04       Impact factor: 5.006

9.  Atypical adenomatous hyperplasia of the prostate. Relationship with carcinoma in 217 whole-mount radical prostatectomies.

Authors:  D G Bostwick; J Qian
Journal:  Am J Surg Pathol       Date:  1995-05       Impact factor: 6.394

10.  Prostatic intra-epithelial neoplasia and early invasion in prostate cancer.

Authors:  D G Bostwick; M K Brawer
Journal:  Cancer       Date:  1987-02-15       Impact factor: 6.860

View more
  10 in total

1.  Improved technique for fluorescence in situ hybridisation analysis of isolated nuclei from archival, B5 or formalin fixed, paraffin wax embedded tissue.

Authors:  M J Schurter; D P LeBrun; K J Harrison
Journal:  Mol Pathol       Date:  2002-04

2.  Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors.

Authors:  Irena Srebotnik-Kirbiš; Clara Limbäck-Stokin
Journal:  J Neurooncol       Date:  2016-07-12       Impact factor: 4.130

3.  Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer.

Authors:  Joachim Woenckhaus; Klaus Steger; Klaus Sturm; Karsten Münstedt; Folker E Franke; Irina Fenic
Journal:  Virchows Arch       Date:  2007-02-15       Impact factor: 4.064

4.  Imbalances of chromosome 17 in medulloblastomas determined by comparative genomic hybridisation and fluorescence in situ hybridisation.

Authors:  J Nicholson; C Wickramasinghe; F Ross; J Crolla; D Ellison
Journal:  Mol Pathol       Date:  2000-12

5.  The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine.

Authors:  I A Sokolova; K C Halling; R B Jenkins; H M Burkhardt; R G Meyer; S A Seelig; W King
Journal:  J Mol Diagn       Date:  2000-08       Impact factor: 5.568

6.  Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?

Authors:  R Shah; N R Mucci; A Amin; J A Macoska; M A Rubin
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

7.  Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas.

Authors:  Bhuvanesh Singh; Archontoula Stoffel; Swarna Gogineni; Ashok Poluri; David G Pfister; Ashok R Shaha; Alok Pathak; George Bosl; Carlos Cordon-Cardo; Jatin P Shah; Pulivarthi H Rao
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  18q21 Rearrangement and trisomy 3 in extranodal B-cell lymphomas: a study using a fluorescent in situ hybridisation technique.

Authors:  Yan-Chin Tai; Jin-Ai Mary Anne Tan; Suat-Cheng Peh
Journal:  Virchows Arch       Date:  2004-09-09       Impact factor: 4.064

9.  TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy.

Authors:  Anuradha Gopalan; Margaret A Leversha; Jaya M Satagopan; Qin Zhou; Hikmat A Al-Ahmadie; Samson W Fine; James A Eastham; Peter T Scardino; Howard I Scher; Satish K Tickoo; Victor E Reuter; William L Gerald
Journal:  Cancer Res       Date:  2009-02-03       Impact factor: 12.701

10.  An assessment of chromosomal alterations detected by fluorescence in situ hybridisation in pancreatobiliary tract malignancy.

Authors:  Xiaohong Pu; Hongwei Zheng; Xin Yang; Qing Ye; Zhiwen Fan; Jun Yang; Xiangshan Fan; Xiaoping Zhou; Yudong Qiu; Qin Huang; Hongyan Wu; Jun Chen
Journal:  BMC Gastroenterol       Date:  2020-11-04       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.